Free Trial
→ The Trump Dump is starting; Get out of stocks now? (From Paradigm Press) (Ad) Buy GERN Stock  Free GERN Stock Alerts

Geron (GERN) Financials

Geron logo
$1.55 +0.04 (+2.65%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$1.57 +0.02 (+1.55%)
As of 04:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Geron

Annual Income Statements for Geron

This table shows Geron's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -36 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175
Consolidated Net Income / (Loss)		 -36 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175
Net Income / (Loss) Continuing Operations		 -36 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175
Total Pre-Tax Income 		-36 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175
Total Operating Income		 -36 -0.56 -31 -29 -31 -73 -77 -114 -139 -194 -174
Total Gross Profit		 1.15 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 76
Total Revenue		 1.15 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 77
Operating Revenue		 1.15 36 6.16 1.07 1.07 0.46 0.25 1.39 0.00 0.00 77
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.26
Operating Cost of Revenue		 - - - - - - - - 0.00 0.00 1.26
Total Operating Expenses		 37 37 37 30 32 73 77 115 139 194 249
Selling, General & Admin Expense		 17 18 19 19 19 21 26 30 44 69 146
Research & Development Expense		 21 18 18 11 13 52 51 86 96 125 104
Total Other Income / (Expense), net		 0.64 0.61 1.11 1.34 4.06 3.96 1.30 -2.11 -3.35 9.82 -0.84
Interest Expense		 - - - - 0.00 0.00 0.76 3.74 6.88 8.31 20
Interest & Investment Income		 0.37 0.68 1.19 1.42 3.25 4.22 1.83 0.53 2.53 18 20
Other Income / (Expense), net		 0.27 -0.07 -0.08 -0.08 0.81 -0.26 0.23 1.10 1.00 -0.02 -0.24
Basic Earnings per Share		 ($0.23) $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27)
Weighted Average Basic Shares Outstanding		 153.54M 158.04M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 380.78M 570.65M 646.03M
Diluted Earnings per Share		 ($0.23) $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27)
Weighted Average Diluted Shares Outstanding		 153.54M 162.66M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 380.78M 570.65M 646.03M
Weighted Average Basic & Diluted Shares Outstanding		 155.10M 158.92M 159.05M 159.22M 176.50M 190.16M 271.46M 327.63M 508.72M 546.06M 636.90M

Quarterly Income Statements for Geron

This table shows Geron's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -41 -43 -38 -49 -45 -52 -55 -67 -26 -25 -20
Consolidated Net Income / (Loss)		 -41 -43 -38 -49 -45 -52 -55 -67 -26 -25 -20
Net Income / (Loss) Continuing Operations		 -41 -43 -38 -49 -45 -52 -55 -67 -26 -25 -20
Total Pre-Tax Income 		-41 -43 -38 -49 -45 -52 -55 -67 -26 -25 -20
Total Operating Income		 -40 -42 -40 -52 -48 -54 -56 -69 -28 -20 -17
Total Gross Profit		 0.30 -0.42 0.00 0.03 0.16 -0.19 0.00 0.87 28 47 38
Total Revenue		 0.30 -0.42 0.00 0.03 0.16 -0.19 0.00 0.88 28 48 40
Operating Revenue		 0.30 - - 0.03 0.16 - - 0.88 28 - 40
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.02 0.46 0.78 1.21
Operating Cost of Revenue		 - - - 0.00 0.00 - - 0.02 0.46 - 1.21
Total Operating Expenses		 40 42 40 52 48 54 56 70 56 67 55
Selling, General & Admin Expense		 16 14 13 16 18 21 27 39 36 43 40
Research & Development Expense		 25 28 27 35 29 33 29 31 20 23 15
Total Other Income / (Expense), net		 -1.10 -0.68 1.97 2.72 2.81 2.32 0.74 1.95 1.77 -5.30 -3.13
Interest Expense		 1.82 2.01 1.92 2.00 2.07 2.32 3.43 3.32 3.05 10 8.20
Interest & Investment Income		 0.85 1.24 3.85 4.74 4.97 4.60 4.24 5.33 4.88 5.16 5.15
Other Income / (Expense), net		 -0.14 0.09 0.04 -0.01 -0.09 0.04 -0.06 -0.06 -0.06 -0.05 -0.08
Basic Earnings per Share		 ($0.10) ($0.11) ($0.07) ($0.09) ($0.08) ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03)
Weighted Average Basic Shares Outstanding		 405.24M 380.78M 544.46M 547.28M 579.51M 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M
Diluted Earnings per Share		 ($0.10) ($0.11) ($0.07) ($0.09) ($0.08) ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03)
Weighted Average Diluted Shares Outstanding		 405.24M 380.78M 544.46M 547.28M 579.51M 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M
Weighted Average Basic & Diluted Shares Outstanding		 381.24M 508.72M 508.77M 523.37M 543.06M 546.06M 593.13M 602.80M 604.50M 636.90M 636.92M

Annual Cash Flow Statements for Geron

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 30 -22 -8.44 3.53 -5.76 3.07 -3.63 25 22 14 9.74
Net Cash From Operating Activities		 9.35 -24 -18 -21 -21 -44 -67 -96 -127 -168 -219
Net Cash From Continuing Operating Activities		 9.35 -24 -18 -21 -21 -44 -67 -96 -127 -168 -219
Net Income / (Loss) Continuing Operations		 -36 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175
Consolidated Net Income / (Loss)		 -36 0.05 -30 -28 -27 -69 -76 -116 -142 -184 -175
Depreciation Expense		 0.05 0.06 0.08 0.08 0.06 0.06 0.16 0.22 0.29 0.44 0.55
Amortization Expense		 2.89 2.10 0.55 0.27 -0.98 -0.82 1.77 2.89 0.94 -9.47 -12
Non-Cash Adjustments To Reconcile Net Income		 7.63 11 10 6.76 7.55 18 6.73 5.90 6.88 21 35
Changes in Operating Assets and Liabilities, net		 34 -37 0.32 0.26 -0.63 7.10 0.30 12 6.41 4.57 -67
Net Cash From Investing Activities		 -78 0.07 8.76 23 -78 27 -105 72 62 -180 -106
Net Cash From Continuing Investing Activities		 -78 0.07 8.76 23 -78 27 -105 72 62 -180 -106
Purchase of Property, Plant & Equipment		 -0.13 -0.09 -0.06 - -0.02 -0.41 -0.40 -0.21 -0.43 -0.83 -0.68
Purchase of Investments		 -190 -206 -129 -100 -188 -153 -313 -177 -258 -476 -477
Sale and/or Maturity of Investments		 112 207 138 123 111 181 208 248 321 296 372
Net Cash From Financing Activities		 98 2.58 1.17 1.11 93 19 168 49 87 362 334
Net Cash From Continuing Financing Activities		 98 2.58 1.17 1.11 93 19 168 49 87 362 334
Repayment of Debt		 - - - - - - - - 0.00 0.00 -87
Issuance of Debt		 - - - - 0.00 0.00 24 25 0.00 30 121
Issuance of Common Equity		 98 2.58 1.17 1.11 93 19 144 21 72 226 173
Other Financing Activities, net		 - - - - 0.00 0.00 0.02 2.48 15 106 126

Quarterly Cash Flow Statements for Geron

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -15 -4.26 56 -56 -26 40 120 -73 -56 19 4.73
Net Cash From Operating Activities		 -30 -35 -46 -30 -51 -41 -62 -53 -59 -44 -48
Net Cash From Continuing Operating Activities		 -30 -35 -46 -30 -51 -41 -62 -53 -59 -44 -48
Net Income / (Loss) Continuing Operations		 -41 -43 -38 -49 -45 -52 -55 -67 -26 -25 -20
Consolidated Net Income / (Loss)		 -41 -43 -38 -49 -45 -52 -55 -67 -26 -25 -20
Depreciation Expense		 0.08 0.08 0.10 0.12 0.11 0.11 0.11 0.26 0.03 0.14 0.13
Amortization Expense		 0.23 -0.58 -1.33 -2.84 -2.96 -2.34 -1.40 -1.67 -1.82 -7.23 -1.78
Non-Cash Adjustments To Reconcile Net Income		 2.18 0.93 3.07 4.04 7.64 6.08 4.97 13 6.91 10 8.67
Changes in Operating Assets and Liabilities, net		 8.98 7.03 -10 18 -11 7.18 -11 2.67 -38 -22 -35
Net Cash From Investing Activities		 9.84 19 -179 -44 -4.71 48 34 -36 -0.55 -104 52
Net Cash From Continuing Investing Activities		 9.84 19 -179 -44 -4.71 48 34 -36 -0.55 -104 52
Purchase of Property, Plant & Equipment		 -0.17 -0.14 -0.37 -0.20 -0.19 -0.06 -0.62 -0.21 - 0.14 0.03
Purchase of Investments		 -40 -161 -242 -114 -104 -16 -66 -161 -66 -185 -46
Sale and/or Maturity of Investments		 50 180 63 70 99 64 100 125 65 81 99
Net Cash From Financing Activities		 4.78 12 281 18 29 33 148 17 3.58 166 0.26
Net Cash From Continuing Financing Activities		 4.78 12 281 18 29 33 148 17 3.58 166 0.26
Issuance of Common Equity		 1.20 0.22 221 0.57 1.04 3.58 148 16 3.57 5.62 0.26
Other Financing Activities, net		 3.64 12 60 18 28 - 0.05 0.37 0.00 126 0.00
Effect of Exchange Rate Changes		 0.01 0.01 -0.02 0.00 0.01 -0.02 -0.01 -0.02 0.05 - 0.02

Annual Balance Sheets for Geron

This table presents Geron's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 173 149 130 110 185 166 271 226 191 394 594
Total Current Assets		 153 116 116 96 166 142 200 187 180 341 491
Cash & Equivalents		 43 21 13 16 11 14 9.93 35 57 70 79
Restricted Cash		 0.27 0.27 0.27 0.27 0.27 0.27 0.36 0.36 0.36 1.12 1.86
Short-Term Investments		 109 93 102 78 153 126 186 149 116 264 328
Note & Lease Receivable		 0.96 1.21 0.48 0.44 1.17 0.80 0.72 1.76 3.14 1.66 2.85
Accounts Receivable		 - - - - - - - - - 0.00 36
Inventories, net		 - - - - - - - - - 0.00 39
Prepaid Expenses		 0.74 0.65 0.52 0.58 1.33 1.21 2.50 1.36 3.99 4.88 5.05
Plant, Property, & Equipment, net		 0.17 0.21 0.18 0.10 0.06 0.41 0.66 0.65 0.79 1.18 1.31
Total Noncurrent Assets		 19 33 14 14 19 24 70 38 9.54 52 101
Long-Term Investments		 19 33 14 14 19 20 63 29 0.00 43 95
Other Noncurrent Operating Assets		 - - - - 0.59 3.85 6.83 9.53 9.54 8.25 6.96
Total Liabilities & Shareholders' Equity		 173 149 130 110 185 166 271 226 191 394 594
Total Liabilities		 42 6.63 7.87 6.52 7.55 30 60 100 111 146 313
Total Current Liabilities		 42 6.63 7.87 6.52 7.55 28 31 46 77 108 88
Short-Term Debt		 - - - - - - - 0.00 21 47 0.00
Accounts Payable		 1.03 0.16 0.23 0.50 0.98 1.18 6.92 6.69 10 6.16 8.60
Accrued Expenses		 1.54 3.45 4.80 0.93 1.32 7.53 15 30 33 40 36
Current Employee Benefit Liabilities		 4.21 3.03 2.84 3.39 2.64 4.83 8.22 8.10 12 14 23
Other Current Liabilities		 0.02 - - 1.70 2.61 15 0.88 0.90 0.93 0.95 21
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 0.00 2.20 29 54 34 38 225
Long-Term Debt		 - - - - - 0.00 24 50 30 35 118
Other Noncurrent Operating Liabilities		 - - - - - 2.20 4.80 4.27 3.67 3.01 107
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 131 142 122 104 178 135 211 126 80 248 280
Total Preferred & Common Equity		 131 142 122 104 178 135 211 126 80 248 280
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 131 142 122 104 178 135 211 126 80 248 280
Common Stock		 1,059 1,071 1,080 1,090 1,189 1,215 1,366 1,398 1,494 1,846 2,052
Retained Earnings		 -928 -928 -958 -986 -1,011 -1,080 -1,156 -1,272 -1,414 -1,598 -1,772
Accumulated Other Comprehensive Income / (Loss)		 -0.08 -0.21 -0.05 -0.21 -0.18 0.13 0.08 -0.17 -0.22 0.19 0.26

Quarterly Balance Sheets for Geron

This table presents Geron's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 233 425 415 413 482 449 445 562
Total Current Assets		 222 387 377 335 452 373 398 496
Cash & Equivalents		 61 113 57 31 190 117 60 84
Restricted Cash		 0.36 0.37 0.54 0.54 1.12 1.12 1.85 1.87
Short-Term Investments		 134 268 314 283 253 246 279 313
Note & Lease Receivable		 22 1.60 1.19 15 1.63 2.25 2.08 2.82
Accounts Receivable		 - - - - - 0.87 28 31
Inventories, net		 - - - - - 0.77 20 56
Prepaid Expenses		 4.70 4.32 4.18 6.27 5.71 5.55 6.06 6.82
Plant, Property, & Equipment, net		 0.73 1.07 1.15 1.23 1.68 1.63 1.60 1.15
Total Noncurrent Assets		 9.80 37 37 77 29 74 45 66
Long-Term Investments		 0.00 28 28 68 21 67 37 59
Other Noncurrent Operating Assets		 9.80 8.69 8.59 8.88 8.10 7.96 7.99 6.74
Total Liabilities & Shareholders' Equity		 233 425 415 413 482 449 445 562
Total Liabilities		 124 99 117 122 137 143 153 294
Total Current Liabilities		 83 44 73 89 123 104 138 63
Short-Term Debt		 13 0.00 11 22 72 47 72 0.00
Accounts Payable		 8.18 3.38 7.67 14 9.99 5.62 14 8.03
Accrued Expenses		 53 35 45 42 34 39 36 29
Current Employee Benefit Liabilities		 7.64 4.91 8.23 11 6.79 11 15 9.60
Other Current Liabilities		 0.92 0.93 0.79 0.94 0.96 0.96 0.97 17
Total Noncurrent Liabilities		 42 55 44 33 14 39 15 231
Long-Term Debt		 38 51 41 30 11 37 12 119
Other Noncurrent Operating Liabilities		 3.83 3.51 3.50 3.18 2.83 2.65 2.46 112
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 108 326 298 291 345 307 292 268
Total Preferred & Common Equity		 108 326 298 291 345 307 292 268
Total Common Equity		 108 326 298 291 345 307 292 268
Common Stock		 1,480 1,778 1,800 1,837 1,998 2,028 2,038 2,060
Retained Earnings		 -1,371 -1,452 -1,501 -1,546 -1,653 -1,721 -1,747 -1,792
Accumulated Other Comprehensive Income / (Loss)		 -0.62 -0.16 -0.95 -0.95 -0.27 -0.54 1.02 0.30

Annual Metrics And Ratios for Geron

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -10.13% 3,054.47% -83.06% -82.72% 0.09% -56.85% -45.00% 450.59% -100.00% 0.00% 0.00%
EBITDA Growth		 11.07% 104.60% -2,076.10% 3.70% -7.60% -135.76% -1.67% -46.88% -24.15% -48.91% 8.60%
EBIT Growth		 8.36% 98.25% -4,769.89% 4.55% -3.19% -140.42% -5.38% -47.22% -21.83% -41.02% 10.31%
NOPAT Growth		 6.79% 97.80% -3,737.60% 4.54% -6.21% -133.34% -6.08% -48.22% -21.54% -39.98% 10.42%
Net Income Growth		 7.06% 100.13% -64,310.87% 5.49% 3.22% -153.72% -10.31% -53.55% -22.21% -29.76% 5.19%
EPS Growth		 23.33% 100.00% 0.00% 5.26% 16.67% -140.00% 22.22% -25.00% -5.71% 13.51% 15.63%
Operating Cash Flow Growth		 125.49% -358.78% 24.08% -11.91% -2.20% -108.62% -52.07% -43.37% -33.30% -31.69% -30.33%
Free Cash Flow Firm Growth		 126.03% -535.48% 46.15% -12.56% -4.48% -36.62% -70.24% -29.21% -33.91% -41.49% 49.28%
Invested Capital Growth		 -537.61% 88.54% -46.20% 19.28% 18.36% -446.65% -3.92% -45.75% -14.97% -14.93% -115.99%
Revenue Q/Q Growth		 -3.92% 0.12% -2.00% 10.02% 20.86% -30.72% -32.35% 373.81% -100.00% 100.00% 165.86%
EBITDA Q/Q Growth		 1.72% 19.64% -1.76% 3.38% -3.65% -40.57% 9.14% -7.53% -9.79% -7.47% 13.63%
EBIT Q/Q Growth		 0.96% 37.77% -0.45% 3.29% -1.94% -42.35% 8.06% -7.30% -8.59% -6.82% 16.41%
NOPAT Q/Q Growth		 0.72% 13.76% -0.45% 3.29% -6.16% -39.20% 8.06% -7.26% -8.60% -6.79% 16.46%
Net Income Q/Q Growth		 0.93% 110.62% -0.05% 3.63% 0.48% -46.54% 6.53% -7.63% -8.09% -5.34% 13.23%
EPS Q/Q Growth		 11.54% 0.00% -5.56% 5.26% 6.25% -44.00% 20.00% -2.94% -5.71% 8.57% 12.90%
Operating Cash Flow Q/Q Growth		 136.06% -353.84% 20.20% -22.57% 6.15% -20.17% -3.49% -11.11% -11.38% -3.55% -1.39%
Free Cash Flow Firm Q/Q Growth		 132.41% -1,639.75% 20.51% -23.50% 3.81% -0.67% -9.25% -10.57% -10.65% -4.46% 63.94%
Invested Capital Q/Q Growth		 -654.91% -18.10% -643.83% -21.33% -240.05% -249.50% -46.95% -23.18% -15.83% -22.47% -3,594.54%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 98.37%
EBITDA Margin		 -2,871.38% 4.19% -488.41% -2,721.41% -2,925.61% -15,984.13% -29,546.64% -7,882.20% 0.00% 0.00% -240.98%
Operating Margin		 -3,149.35% -1.54% -497.34% -2,746.95% -2,914.92% -15,761.96% -30,400.40% -8,183.70% 0.00% 0.00% -225.64%
EBIT Margin		 -3,126.02% -1.73% -498.69% -2,754.18% -2,839.40% -15,819.35% -30,310.28% -8,104.74% 0.00% 0.00% -225.95%
Profit (Net Income) Margin		 -3,093.67% 0.13% -479.34% -2,621.22% -2,534.43% -14,901.74% -29,888.14% -8,335.39% 0.00% 0.00% -226.73%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 98.97% -7.29% 96.12% 95.17% 89.26% 94.20% 98.61% 102.85% 103.16% 94.93% 100.35%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -37.45% 0.03% -22.33% -24.69% -19.19% -43.82% -43.70% -68.84% -137.49% -112.29% -66.09%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -30.05% -0.39% -22.03% -24.39% -20.48% -41.49% -35.16% -45.45% 0.00% 0.00% -35.22%
Return on Assets (ROA)		 -29.74% 0.03% -21.17% -23.21% -18.28% -39.08% -34.67% -46.75% 0.00% 0.00% -35.34%
Return on Common Equity (ROCE)		 -37.45% 0.03% -22.33% -24.69% -19.19% -43.82% -43.70% -68.84% -137.49% -112.29% -66.09%
Return on Equity Simple (ROE_SIMPLE)		 -27.29% 0.03% -24.14% -26.89% -15.20% -50.72% -35.85% -91.85% -177.38% -74.26% -62.28%
Net Operating Profit after Tax (NOPAT)		 -25 -0.56 -21 -20 -22 -51 -54 -80 -97 -136 -122
NOPAT Margin		 -2,204.54% -1.54% -348.14% -1,922.86% -2,040.44% -11,033.37% -21,280.28% -5,728.59% 0.00% 0.00% -157.95%
Net Nonoperating Expense Percent (NNEP)		 -8.66% 0.38% -5.86% -6.24% -3.62% -10.42% -11.02% -18.21% -31.54% -23.14% -15.56%
Return On Investment Capital (ROIC_SIMPLE)		 -19.45% -0.39% -17.53% -19.73% -12.24% -37.55% -22.91% -45.28% -73.95% -41.15% -30.49%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.63%
SG&A Expenses to Revenue		 1,453.43% 48.92% 304.46% 1,810.99% 1,754.88% 4,541.96% 10,149.41% 2,129.58% 0.00% 0.00% 189.28%
R&D to Revenue		 1,795.92% 49.03% 292.88% 1,035.96% 1,260.04% 11,320.00% 20,350.99% 6,154.13% 0.00% 0.00% 134.74%
Operating Expenses to Revenue		 3,249.35% 101.54% 597.34% 2,846.95% 3,014.92% 15,861.96% 30,500.40% 8,283.70% 0.00% 0.00% 324.01%
Earnings before Interest and Taxes (EBIT)		 -36 -0.63 -31 -29 -30 -73 -77 -113 -138 -194 -174
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -33 1.52 -30 -29 -31 -74 -75 -110 -136 -203 -186
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.91 5.39 2.69 2.76 1.05 2.01 2.34 3.11 11.53 4.62 7.63
Price to Tangible Book Value (P/TBV)		 3.91 5.39 2.69 2.76 1.05 2.01 2.34 3.11 11.53 4.62 7.63
Price to Revenue (P/Rev)		 443.14 21.06 53.46 269.12 174.81 590.65 1,951.19 281.97 0.00 0.00 27.79
Price to Earnings (P/E)		 0.00 16,647.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 295.14 17.02 32.52 166.59 3.95 244.46 1,018.45 165.02 0.00 0.00 22.80
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 406.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 36.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 41.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.39 0.64 0.33 0.42
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.39 0.38 0.14 0.42
Financial Leverage		 -1.24 -1.16 -1.04 -1.05 -1.03 -1.09 -1.14 -1.18 -1.38 -1.28 -1.29
Leverage Ratio		 1.26 1.18 1.05 1.06 1.05 1.12 1.26 1.47 2.02 1.78 1.87
Compound Leverage Factor		 1.25 -0.09 1.01 1.01 0.94 1.06 1.24 1.51 2.08 1.69 1.88
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.23% 28.27% 39.01% 24.84% 29.71%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 15.97% 14.21% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.23% 28.27% 23.04% 10.63% 29.71%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 89.77% 71.73% 61.00% 75.16% 70.29%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 -0.32 -0.45 -0.38 -0.40 -0.64
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 3.16 1.48 0.89 1.46 2.07
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 -0.32 -0.45 -0.22 -0.17 -0.64
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 -0.45 -0.62 -0.53 -0.60 -0.97
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 4.38 2.04 1.26 2.18 3.16
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 -0.45 -0.62 -0.31 -0.26 -0.97
Altman Z-Score		 -0.11 61.64 15.09 13.99 7.66 -4.39 -1.21 -6.40 -7.11 -1.89 -0.11
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.67 17.47 14.76 14.73 21.99 5.03 6.46 4.11 2.35 3.16 5.56
Quick Ratio		 3.65 17.33 14.66 14.60 21.78 4.98 6.37 4.07 2.29 3.10 5.04
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 8.25 -36 -19 -22 -23 -31 -53 -68 -92 -129 -66
Operating Cash Flow to CapEx		 7,137.40% -26,884.44% -44,802.44% 0.00% -131,306.25% -10,612.35% -107,503.23% 0.00% -29,554.29% -20,210.00% -32,149.71%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -69.60 -18.27 -13.30 -15.58 -3.25
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -87.70 -25.55 -18.51 -20.18 -10.82
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -87.78 -25.18 -18.57 -20.28 -10.85
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.01 0.23 0.04 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.16
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 8.70 191.43 31.60 7.47 13.24 1.97 0.47 2.13 0.00 0.00 61.92
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.17
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2,144.08
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2,144.08
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -40 -4.57 -6.69 -5.40 -4.41 -24 -25 -36 -42 -48 -104
Invested Capital Turnover		 -0.05 -1.63 -1.09 -0.18 -0.22 -0.03 -0.01 -0.05 0.00 0.00 -1.01
Increase / (Decrease) in Invested Capital		 -34 35 -2.11 1.29 0.99 -20 -0.95 -11 -5.46 -6.26 -56
Enterprise Value (EV)		 340 619 200 177 4.21 112 258 230 801 850 1,755
Market Capitalization		 511 766 329 287 186 272 494 393 923 1,146 2,140
Book Value per Share		 $0.83 $0.90 $0.77 $0.65 $0.95 $0.68 $0.68 $0.39 $0.21 $0.46 $0.46
Tangible Book Value per Share		 $0.83 $0.90 $0.77 $0.65 $0.95 $0.68 $0.68 $0.39 $0.21 $0.46 $0.46
Total Capital		 131 142 122 104 178 135 235 176 131 330 399
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 24 50 51 82 118
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 24 50 30 35 118
Net Debt		 -171 -147 -129 -109 -182 -159 -236 -163 -122 -296 -384
Capital Expenditures (CapEx)		 0.13 0.09 0.04 0.00 0.02 0.41 0.06 -1.39 0.43 0.83 0.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -40 -4.78 -6.87 -5.50 -5.05 -26 -28 -42 -49 -55 -5.73
Debt-free Net Working Capital (DFNWC)		 112 109 108 89 159 113 169 142 124 280 403
Net Working Capital (NWC)		 112 109 108 89 159 113 169 142 104 233 403
Net Nonoperating Expense (NNE)		 10 -0.61 8.08 7.44 5.27 18 22 36 45 48 53
Net Nonoperating Obligations (NNO)		 -171 -147 -129 -109 -182 -159 -236 -163 -122 -296 -384
Total Depreciation and Amortization (D&A)		 2.94 2.15 0.63 0.35 -0.92 -0.76 1.93 3.10 1.23 -9.03 -12
Debt-free, Cash-free Net Working Capital to Revenue		 -3,477.88% -13.15% -111.49% -516.43% -473.83% -5,684.57% -10,956.92% -3,043.86% 0.00% 0.00% -7.44%
Debt-free Net Working Capital to Revenue		 9,679.71% 300.40% 1,756.62% 8,399.44% 14,869.32% 24,662.17% 66,765.61% 10,171.21% 0.00% 0.00% 523.02%
Net Working Capital to Revenue		 9,679.71% 300.40% 1,756.62% 8,399.44% 14,869.32% 24,662.17% 66,765.61% 10,171.21% 0.00% 0.00% 523.02%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.23) $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27)
Adjusted Weighted Average Basic Shares Outstanding		 157.70M 158.04M 159.05M 159.22M 186.39M 200.34M 318.53M 323.73M 380.78M 570.65M 646.03M
Adjusted Diluted Earnings per Share		 ($0.23) $0.00 ($0.19) ($0.18) ($0.15) ($0.36) ($0.28) ($0.35) ($0.37) ($0.32) ($0.27)
Adjusted Weighted Average Diluted Shares Outstanding		 157.70M 162.66M 159.05M 159.22M 186.39M 200.34M 318.53M 323.73M 380.78M 570.65M 646.03M
Adjusted Basic & Diluted Earnings per Share		 ($0.23) $0.00 $0.00 $0.00 ($0.15) ($0.36) ($0.28) ($0.35) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 153.54M 158.92M 159.16M 160.65M 176.50M 190.16M 271.46M 327.63M 508.72M 546.06M 636.90M
Normalized Net Operating Profit after Tax (NOPAT)		 -25 0.52 -21 -20 -22 -51 -54 -80 -97 -136 -122
Normalized NOPAT Margin		 -2,204.54% 1.44% -348.14% -1,922.86% -2,040.44% -11,033.37% -21,280.28% -5,728.59% 0.00% 0.00% -157.95%
Pre Tax Income Margin		 -3,093.67% 0.13% -479.34% -2,621.22% -2,534.43% -14,901.74% -29,888.14% -8,335.39% 0.00% 0.00% -226.73%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -100.90 -30.19 -19.99 -23.34 -8.61
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -70.84 -21.34 -14.09 -16.33 -6.02
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -100.98 -29.82 -20.05 -23.44 -8.64
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -70.92 -20.97 -14.16 -16.43 -6.05
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Geron

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% -136.55% -100.00% 0.00% -44.78% 54.05% 0.00% 2,941.38% 17,138.41% 24,888.08% 12,927.30%
EBITDA Growth		 -59.43% -40.25% -47.52% -108.80% -27.10% -33.30% -39.24% -29.49% 40.53% 51.86% 67.93%
EBIT Growth		 -55.67% -35.10% -39.41% -93.41% -19.00% -29.58% -40.30% -33.55% 40.72% 62.95% 70.13%
NOPAT Growth		 -55.60% -35.40% -39.82% -85.70% -19.18% -29.41% -40.01% -33.46% 40.74% 63.07% 70.24%
Net Income Growth		 -53.77% -33.16% -26.66% -75.08% -9.14% -21.90% -45.30% -36.88% 40.97% 51.22% 64.19%
EPS Growth		 -25.00% -22.22% 22.22% -28.57% 20.00% 27.27% -28.57% -11.11% 50.00% 50.00% 66.67%
Operating Cash Flow Growth		 -29.52% -58.70% -36.47% -3.35% -71.86% -16.36% -34.27% -80.66% -15.94% -7.35% 22.93%
Free Cash Flow Firm Growth		 -296.70% -133.59% -194.06% 35.76% -41.24% -32.79% -26.60% -335.14% -86.58% 232.00% 163.90%
Invested Capital Growth		 -22.27% -14.97% -4.75% -84.38% -8.70% -14.93% -17.59% 19.74% 92.84% -115.99% -89.01%
Revenue Q/Q Growth		 0.00% -241.41% 100.00% 0.00% 465.52% -217.68% 100.00% 0.00% 3,105.33% 69.22% -17.22%
EBITDA Q/Q Growth		 -51.89% -6.52% 2.55% -32.43% 7.54% -11.71% -1.79% -23.17% 57.54% 9.57% 32.19%
EBIT Q/Q Growth		 -49.21% -4.44% 4.33% -29.73% 8.19% -13.72% -3.59% -23.49% 59.25% 28.93% 16.47%
NOPAT Q/Q Growth		 -42.79% -5.01% 4.43% -29.58% 8.35% -14.02% -3.40% -23.51% 59.31% 28.94% 16.69%
Net Income Q/Q Growth		 -46.00% -3.86% 10.59% -29.13% 8.98% -16.00% -6.57% -21.65% 60.75% 4.14% 21.76%
EPS Q/Q Growth		 -42.86% -10.00% 36.36% -28.57% 11.11% 0.00% -12.50% -11.11% 60.00% 0.00% 25.00%
Operating Cash Flow Q/Q Growth		 -3.28% -18.93% -31.79% 36.16% -71.75% 19.48% -52.07% 14.10% -10.22% 25.44% -9.18%
Free Cash Flow Firm Q/Q Growth		 -2.22% -11.87% -11.40% 49.57% -124.76% -5.17% -6.21% -73.32% 3.63% 174.41% -48.58%
Invested Capital Q/Q Growth		 -33.24% -15.83% 24.32% -57.86% 21.45% -22.47% 22.57% -7.75% 92.99% -3,594.54% 32.24%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 0.00% 0.00% 100.00% 100.00% 0.00% 0.00% 98.07% 98.39% 98.36% 96.95%
EBITDA Margin		 -13,392.26% 0.00% 0.00% -188,544.83% -30,826.22% 0.00% 0.00% -8,027.55% -106.34% -56.83% -46.55%
Operating Margin		 -13,450.51% 0.00% 0.00% -179,141.38% -29,031.71% 0.00% 0.00% -7,860.88% -99.80% -41.91% -42.18%
EBIT Margin		 -13,496.97% 0.00% 0.00% -179,179.31% -29,087.80% 0.00% 0.00% -7,868.03% -100.02% -42.01% -42.39%
Profit (Net Income) Margin		 -13,821.89% 0.00% 0.00% -169,748.28% -27,320.12% 0.00% 0.00% -7,639.80% -93.55% -52.99% -50.08%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 102.41% 101.84% 95.18% 94.74% 93.92% 95.81% 98.57% 97.10% 93.53% 126.14% 118.16%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -101.09% -137.49% -70.80% -77.66% -87.66% -112.29% -60.04% -72.56% -69.03% -66.09% -45.35%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -91.73% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -15.52% -6.75% -6.55% -9.44%
Return on Assets (ROA)		 -93.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -15.07% -6.32% -8.26% -11.15%
Return on Common Equity (ROCE)		 -101.09% -137.49% -70.80% -77.66% -87.66% -112.29% -60.04% -72.56% -69.03% -66.09% -45.35%
Return on Equity Simple (ROE_SIMPLE)		 -121.37% 0.00% -45.98% -57.31% -60.14% 0.00% -58.40% -71.59% -68.83% 0.00% -51.83%
Net Operating Profit after Tax (NOPAT)		 -28 -29 -28 -36 -33 -38 -39 -49 -20 -14 -12
NOPAT Margin		 -9,415.35% 0.00% 0.00% -125,398.97% -20,322.20% 0.00% 0.00% -5,502.62% -69.86% -29.34% -29.53%
Net Nonoperating Expense Percent (NNEP)		 -8.04% -9.32% -4.14% -4.97% -4.84% -6.68% -4.35% -5.42% -2.14% -3.33% -2.26%
Return On Investment Capital (ROIC_SIMPLE)		 -17.59% -22.39% -7.44% -10.39% -9.73% -11.52% -9.19% -12.44% -5.25% -3.52% -3.02%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.93% 1.61% 1.64% 3.05%
SG&A Expenses to Revenue		 5,266.67% 0.00% 0.00% 56,862.07% 11,189.02% 0.00% 0.00% 4,469.27% 126.90% 90.66% 101.06%
R&D to Revenue		 8,283.84% 0.00% 0.00% 122,379.31% 17,942.68% 0.00% 0.00% 3,489.68% 71.29% 48.98% 38.07%
Operating Expenses to Revenue		 13,550.51% 0.00% 0.00% 179,241.38% 29,131.71% 0.00% 0.00% 7,958.96% 198.19% 139.64% 139.13%
Earnings before Interest and Taxes (EBIT)		 -40 -42 -40 -52 -48 -54 -56 -69 -28 -20 -17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -40 -42 -41 -55 -51 -56 -57 -71 -30 -27 -18
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 8.17 11.53 3.39 5.47 3.82 4.62 5.23 8.20 9.36 7.63 3.78
Price to Tangible Book Value (P/TBV)		 8.17 11.53 3.39 5.47 3.82 4.62 5.23 8.20 9.36 7.63 3.78
Price to Revenue (P/Rev)		 563.48 0.00 0.00 0.00 0.00 0.00 0.00 2,948.28 94.50 27.79 8.71
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 471.45 0.00 0.00 0.00 0.00 0.00 0.00 2,541.57 84.31 22.80 5.79
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.47 0.64 0.16 0.17 0.18 0.33 0.24 0.27 0.29 0.42 0.44
Long-Term Debt to Equity		 0.35 0.38 0.16 0.14 0.10 0.14 0.03 0.12 0.04 0.42 0.44
Financial Leverage		 -1.25 -1.38 -1.15 -1.18 -1.19 -1.28 -1.10 -1.15 -1.07 -1.29 -1.18
Leverage Ratio		 1.78 2.02 1.47 1.48 1.62 1.78 1.35 1.43 1.47 1.87 1.70
Compound Leverage Factor		 1.82 2.06 1.40 1.41 1.52 1.71 1.33 1.39 1.38 2.36 2.01
Debt to Total Capital		 31.94% 39.01% 13.62% 14.75% 15.15% 24.84% 19.35% 21.39% 22.29% 29.71% 30.68%
Short-Term Debt to Total Capital		 8.15% 15.97% 0.00% 3.10% 6.44% 14.21% 16.73% 12.03% 19.03% 0.00% 0.00%
Long-Term Debt to Total Capital		 23.78% 23.04% 13.62% 11.66% 8.71% 10.63% 2.62% 9.36% 3.26% 29.71% 30.68%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.06% 61.00% 86.38% 85.25% 84.85% 75.16% 80.65% 78.61% 77.71% 70.29% 69.32%
Debt to EBITDA		 -0.41 -0.38 -0.34 -0.29 -0.27 -0.40 -0.38 -0.35 -0.39 -0.64 -0.81
Net Debt to EBITDA		 1.16 0.89 2.39 1.96 1.75 1.46 1.74 1.47 1.37 2.07 2.31
Long-Term Debt to EBITDA		 -0.30 -0.22 -0.34 -0.23 -0.16 -0.17 -0.05 -0.16 -0.06 -0.64 -0.81
Debt to NOPAT		 -0.57 -0.53 -0.49 -0.42 -0.41 -0.60 -0.56 -0.52 -0.58 -0.97 -1.26
Net Debt to NOPAT		 1.62 1.26 3.41 2.86 2.60 2.18 2.60 2.18 2.03 3.16 3.60
Long-Term Debt to NOPAT		 -0.42 -0.31 -0.49 -0.34 -0.23 -0.26 -0.08 -0.23 -0.08 -0.97 -1.26
Altman Z-Score		 -3.83 -5.45 2.58 3.79 0.53 -0.72 3.51 5.43 5.82 0.75 -1.36
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.68 2.35 8.81 5.20 3.75 3.16 3.67 3.61 2.89 5.56 7.87
Quick Ratio		 2.62 2.29 8.71 5.13 3.67 3.10 3.61 3.53 2.68 5.04 6.84
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -21 -24 -27 -13 -30 -32 -34 -58 -56 42 22
Operating Cash Flow to CapEx		 -17,299.42% -25,129.29% -12,463.71% -14,653.96% -26,478.65% -63,965.63% -10,122.44% -25,960.19% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -11.76 -11.92 -13.85 -6.70 -14.61 -13.67 -9.82 -17.60 -18.48 4.02 2.63
Operating Cash Flow to Interest Expense		 -16.28 -17.55 -24.12 -14.78 -24.61 -17.64 -18.13 -16.11 -19.35 -4.22 -5.85
Operating Cash Flow Less CapEx to Interest Expense		 -16.37 -17.62 -24.32 -14.88 -24.70 -17.67 -18.31 -16.17 -19.35 -4.21 -5.85
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.16 0.22
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 2.34 0.00 0.00 0.00 0.00 0.00 0.00 0.62 20.50 61.92 82.24
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.17 0.27
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 142,704.26 10,578.83 2,144.08 1,336.06
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -142,704.26 -10,578.83 -2,144.08 -1,336.06
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -36 -42 -32 -50 -39 -48 -37 -40 -2.82 -104 -71
Invested Capital Turnover		 -0.05 0.00 0.00 0.00 0.00 0.00 0.00 -0.02 -1.37 -1.01 -2.16
Increase / (Decrease) in Invested Capital		 -6.60 -5.46 -1.44 -23 -3.15 -6.26 -5.59 9.89 37 -56 -33
Enterprise Value (EV)		 740 801 746 1,285 780 850 1,420 2,168 2,442 1,755 674
Market Capitalization		 884 923 1,104 1,633 1,110 1,146 1,802 2,515 2,737 2,140 1,013
Book Value per Share		 $0.29 $0.21 $0.64 $0.59 $0.56 $0.46 $0.63 $0.52 $0.48 $0.46 $0.42
Tangible Book Value per Share		 $0.29 $0.21 $0.64 $0.59 $0.56 $0.46 $0.63 $0.52 $0.48 $0.46 $0.42
Total Capital		 159 131 377 350 343 330 428 390 376 399 387
Total Debt		 51 51 51 52 52 82 83 83 84 118 119
Total Long-Term Debt		 38 30 51 41 30 35 11 37 12 118 119
Net Debt		 -144 -122 -358 -349 -330 -296 -382 -347 -295 -384 -339
Capital Expenditures (CapEx)		 0.17 0.14 0.37 0.20 0.19 0.06 0.62 0.21 0.00 -0.14 -0.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -43 -49 -38 -56 -46 -55 -44 -47 -9.94 -5.73 34
Debt-free Net Working Capital (DFNWC)		 152 124 343 316 268 280 400 317 332 403 433
Net Working Capital (NWC)		 139 104 343 305 246 233 328 270 260 403 433
Net Nonoperating Expense (NNE)		 13 13 10 13 11 14 16 19 6.70 11 8.14
Net Nonoperating Obligations (NNO)		 -144 -122 -358 -349 -330 -296 -382 -347 -295 -384 -339
Total Depreciation and Amortization (D&A)		 0.31 -0.50 -1.23 -2.72 -2.85 -2.23 -1.29 -1.41 -1.79 -7.09 -1.65
Debt-free, Cash-free Net Working Capital to Revenue		 -2,736.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -5,530.13% -34.33% -7.44% 29.23%
Debt-free Net Working Capital to Revenue		 9,701.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 37,126.03% 1,145.32% 523.02% 372.11%
Net Working Capital to Revenue		 8,875.78% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 31,625.79% 898.22% 523.02% 372.11%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.10) ($0.11) ($0.07) ($0.09) ($0.08) ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03)
Adjusted Weighted Average Basic Shares Outstanding		 405.24M 380.78M 544.46M 547.28M 579.51M 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M
Adjusted Diluted Earnings per Share		 ($0.10) ($0.11) ($0.07) ($0.09) ($0.08) ($0.08) ($0.09) ($0.10) ($0.04) ($0.04) ($0.03)
Adjusted Weighted Average Diluted Shares Outstanding		 405.24M 380.78M 544.46M 547.28M 579.51M 570.65M 603.49M 653.90M 662.16M 646.03M 665.91M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 381.24M 508.72M 508.77M 523.37M 543.06M 546.06M 593.13M 602.80M 604.50M 636.90M 636.92M
Normalized Net Operating Profit after Tax (NOPAT)		 -28 -29 -28 -36 -33 -38 -39 -49 -20 -14 -12
Normalized NOPAT Margin		 -9,415.35% 0.00% 0.00% -125,398.97% -20,322.20% 0.00% 0.00% -5,502.62% -69.86% -29.34% -29.53%
Pre Tax Income Margin		 -13,821.89% 0.00% 0.00% -169,748.28% -27,320.12% 0.00% 0.00% -7,639.80% -93.55% -52.99% -50.08%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -22.06 -20.88 -20.84 -25.94 -23.09 -23.37 -16.37 -20.91 -9.28 -1.93 -2.05
NOPAT to Interest Expense		 -15.39 -14.65 -14.60 -18.16 -16.13 -16.37 -11.45 -14.62 -6.48 -1.35 -1.43
EBIT Less CapEx to Interest Expense		 -22.16 -20.95 -21.03 -26.04 -23.18 -23.40 -16.55 -20.97 -9.28 -1.92 -2.04
NOPAT Less CapEx to Interest Expense		 -15.48 -14.72 -14.80 -18.26 -16.22 -16.40 -11.63 -14.68 -6.48 -1.33 -1.42
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Geron's Financials

When does Geron's fiscal year end?

According to the most recent income statement we have on file, Geron's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Geron's net income changed over the last 10 years?

Geron's net income appears to be on an upward trend, with a most recent value of -$174.57 million in 2024, rising from -$35.67 million in 2014. The previous period was -$184.13 million in 2023. View Geron's forecast to see where analysts expect Geron to go next.

What is Geron's operating income?
Geron's total operating income in 2024 was -$173.73 million, based on the following breakdown:
  • Total Gross Profit: $75.74 million
  • Total Operating Expenses: $249.47 million
How has Geron's revenue changed over the last 10 years?

Over the last 10 years, Geron's total revenue changed from $1.15 million in 2014 to $76.99 million in 2024, a change of 6,577.7%.

How much debt does Geron have?

Geron's total liabilities were at $313.46 million at the end of 2024, a 114.5% increase from 2023, and a 649.9% increase since 2014.

How much cash does Geron have?

In the past 10 years, Geron's cash and equivalents has ranged from $9.93 million in 2020 to $79.02 million in 2024, and is currently $79.02 million as of their latest financial filing in 2024.

How has Geron's book value per share changed over the last 10 years?

Over the last 10 years, Geron's book value per share changed from 0.83 in 2014 to 0.46 in 2024, a change of -44.2%.


Related Companies

This page (NASDAQ:GERN) was last updated on 6/17/2025 by MarketBeat.com Staff
From Our Partners
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...
American Alternative | Sponsored
Why July 22nd Could Mean Big Changes for Social Security
In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...
Altimetry | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
Will I be blacklisted?
The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...
Porter & Company | Sponsored